SSRI products

Physicians' survey database

PatientsMap

PatientsMap is a large-scale database that contains data collected from physicians in four of the world’s major countries. Providing disease-related market data, it is helpful as a very versatile tool that can be used to address a wide range of issues from the development of new treatments to their post-market launch.


When you are faced with problems such as …?
  • Difficulty selecting diseases for which new treatments should be developed,
  • Difficulty estimating the number of physicians needed to achieve sales,
  • Uncertainty about visit overlap for a particular disease for which new products are indicated is hindering indication expansion, and
  • Being unable to understand competitors’ current promotions,    etc.
PatientsMap is the perfect solution to these problems as it provides extensive data and analysis.
For inquiries, please click here.   >


Services overview

PatientsMap is a product that allows you to obtain comprehensive information on the treatment landscape and market size of more than approximately 1,000 diseases including rare diseases, unmet needs, and the promotional status of various pharmaceutical manufacturers.
The data on physicians' unmet needs for "diseases that require new treatments" gives PatientsMap its own unique value.

01
Treatment landscape and market size
PatientsMap provides data on treatment landscape by disease, number of patients, and number of treating physicians by disease.
02
Physicians’ unmet needs
PatientsMap highlights diseases that require new treatments and why.
03
Promotions
PatientsMap provides data on the number of MR visits, online meetings, e-detailing, and their reliability.
*Physician background data are also available.
*Survey items may vary depending on the product.

Product features

PatientsMap is an optimal product to understand the overall trend in a disease area with a large sample size and wide coverage.
It can also be used to compare and analyze the data chronologically or by country based on data collected in the same survey frame.

Massive sample size
One of the largest physician surveys in Japan
PatientsMap provides highly accurate data based on surveys of 20,000 physicians in Japan and 6,000 physicians in the US.
It is one of the largest physician surveys in Japan.
Broad disease coverage including rare diseases
PatientsMap has a track record of approximately 1,000 diseases to date and provides extensive knowledge on rare diseases as well as designated intractable diseases.
(As of October 2024, it covers approximately 86% of designated intractable diseases.)
Global scale
PatientsMap covers four of the world’s major markets – Japan, the US, China, and the UK – and provides useful information when considering overseas expansion.
Allows for trends by country to be understood with consistent data
It provides information so trends by year and characteristics by country can be understood with accumulated data that have been collected consistently in the same survey frame since 2011.


Data usage suggestions
PatientsMap is useful for understanding key information in the disease market and make strategic decisions.
It can help you in various areas such as research and development, business and product strategy, market research, and sales and marketing.

Insight into treatment landscape

PatientsMap can help you design control strategies for each segment as it can show a detailed treatment landscape by physician specialty or facility size.

Insight into disease market size

PatientsMap can help you by providing fundamental data that allow you to understand market size and make investment decisions based on information about the number of patients and physicians in each disease area.

Insight into disease market concentration

PatientsMap can help you understand market concentration based on the number of patients and physicians to effectively narrow down target markets.

Insight into unmet needs

PatientsMap can help you understand the differences in the need for new therapy for each disease, from common diseases to rare diseases, and the reasons for these differences, so the direction and priority of new treatment development can be considered.

Insight into the accuracy of physician targeting

The Japanese version of PatientsMap data can help you assess target physician coverage through target matching with DCF codes and evaluate targeting accuracy.

Insight into competitor promotions

PatientsMap can help you to understand the reach and reliability of each pharmaceutical manufacturer’s promotional activities by information media so you can understand the competitive landscape for treating physicians.
PatientsMap can help you in various situations.

Actual analysis cases
We have shared PatientsMap data analysis results via our press releases and newsletters. Here are some examples to help you gain practical insights from PatientsMap data.

Market size and treatment status analysis


Analysis of unmet needs


Analysis of the promotional status of each pharmaceutical company


Other cases of our analyses can be found below:

For inquiries about problem solving
If you are experiencing any of the problems below,
please contact us.
Our dedicated staff will be happy to provide a demonstrative analysis and individual consultation for cases such as:
  • When considering a disease for which new treatments should be developed,
  • When verifying the disease market for in-licensed new developments or considering a partnered licensee,
  • When estimating the number of physicians needed to achieve sales,
  • When attempting to capture visit overlap for a particular disease to expand the product indications for that disease, and
  • When evaluating the current target physicians,    etc.
For inquiries, please click here.   >
Please email us at patientsmap@ssri.com for inquiries.
scroll top